Dr. Malcolm A. S. Moore is the Enid A. Haupt Chair of Cell Biology at the Memorial Sloan Kettering Cancer Center. Dr. Moore has made many contributions, including discovering granulocyte colony stimulating factor (G-CSF), which can stimulate the production of immune cells. He also led the development of filgrastim, which uses G-CSF to boost numbers of immune cells known as neutrophils. For these accomplishments, he received the 1995 William B. Coley Award. Dr. Moore has been a member of CRI’s Scientific Advisory Council since 1990.
It is our hope that future drugs designed to interrupt cancer cells from communicating via nanotubes could help bring us closer to a variety of new treatment options for patients with aggressive cancers.
Let's spread the word about Immunotherapy! Click to share this page with your community.